07:18 AM EDT, 06/12/2025 (MT Newswires) -- Merck & Co. ( MRK ) said Thursday that it initiated the MOBILIZE-1 phase 3 clinical trial evaluating V181 for the prevention of dengue.
The company has started recruitment for the study, with the first participants now enrolling in Singapore.